Pubblicazioni

Acquired thrombotic thrombocytopenic purpura in a child: Rituximab to prevent relapse. A pediatric report and literature review

2018 - HAEMATOLOGICA

Mariani, Sabrina; Trisolini, Silvia M.; Capria, Saveria; Moleti, Maria L.; Chisini, Marta; Ferrazza, Giancarlo; Bafti, Mahnaz Shafii; Limongiello, Maria A.; Miulli, Eleonora; Peyvandi, Flora; FoÃ , Robin; Testi, Anna M.

Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study

2018 - HAEMATOLOGICA

Cuneo, Antonio; Follows, George; Rigolin, Gian Matteo; Piciocchi, Alfonso; Tedeschi, Alessandra; Trentin, Livio; Medina Perez, Angeles; Coscia, Marta; Laurenti, Luca; Musuraca, Gerardo; Farina, Lucia; Rivas Delgado, Alfredo; Orlandi, Ester Maria; Galieni, Piero; Mauro, Francesca Romana; Visco, Carlo; Amendola, Angela; Billio, Atto; Marasca, Roberto; Chiarenza, Annalisa; Meneghini, Vittorio; Ilariucci, Fiorella; Marchetti, Monia; Molica, Stefano; Re, Francesca; Gaidano, Gianluca; Gonzalez, Marcos; Forconi, Francesco; Ciolli, Stefania; Cortelezzi, Agostino; Montillo, Marco; Smolej, Lukas; Schuh, Anna; Eyre, Toby A; Kennedy, Ben; Bowles, Kris M; Vignetti, Marco; de la Serna, Javier; Moreno, Carol; FoÃ , Robin; Ghia, Paolo

Development of a combination strategy based on ER and oxidativa stress to target acute myeloid leukemia

2018 - HAEMATOLOGICAHAEMATOLOGICA

Masciarelli, Silvia; Capuano, E.; Ottone, T.; Divona, M.; Lavorgna, S.; Picardi, A.; Voso, M. T.; Lo-Coco, F.; Fazi, Francesco

Prognostic implications of additional genomic lesions in adult Ph+ acute lymphoblastic leukemia

2018 - HAEMATOLOGICA

Fedullo, Al; Messina, M; Elia, L; Piciocchi, A; Gianfelici, V; Lauretti, A; Soddu, S; Puzzolo, Mc; Minotti, C; Ferrara, F; Martino, B; Chiusolo, P; Calafiore, V; Paolini, S; Vignetti, M; Vitale, A; Guarini, A; FoÃ , R; Chiaretti, S.

Safety of obinutuzumab alone or combined with chemotherapy for previously untreated or relapsed/refractory chronic lymphocytic leukemia in the Phase 3b GREEN study

2018 - HAEMATOLOGICA

Leblond, V; Aktan, M; Ferra Coll CM, ; Dartigeas, C; Kisro, J; Montillo, M; Raposo, J; Merot, Jl; Robson, S; Gresko, E; Bosch, F; Stilgenbauer, S; FoÃ , R

Transcriptional activation of the miR-17-92 cluster is involved in the growth-promoting effects of MYB in human Ph-positive leukemia cells

2018 - HAEMATOLOGICA

Spagnuolo, Manuela; Regazzo, Giulia; De Dominici, Marco; Sacconi, Andrea; Pelosi, Andrea; Korita, Etleva; Marchesi, Francesco; Pisani, Francesco; Magenta, Alessandra; Lulli, Valentina; Cordone, Iole; Mengarelli, Andrea; Strano, Sabrina; Blandino, Giovanni; Rizzo, Maria G; Calabretta, Bruno

A novel germline mutation in the 3'Untranslated region of Calreticulin gene induces JAK/STAT signaling activation and Erythrocytosis.

2018 - HAEMATOLOGICA

Quattrocchi, Alberto; Tomassini, Simona; Billi, M.; Scerpa, Mc.; Cenfra, N.; Gentile, Martina; Maiorca, Carlo; Ceccherelli, A.; De Marinis, E.; Grignani, F.; Cimino, G.; Nervi, C.

TARGETING SIGLEC-7: A NOVEL IMMUNOTHERAPEUTIC APPROACH TO POTENTIATE THE CYTOTOXIC FUNCTIONS OF NATURAL KILLER CELLS AGAINST MULTIPLE MYELOMA

2018 - HAEMATOLOGICA

Daly, J; Sarkar, S; Natoni, A; Hu, J; Chauhan, S; Henderson, R; Duggan, T; Mccarthy, Pl; Mcellistrim, C; O'Dwyer, M

Low dose cyclophosphamide potentiates the anti-myeloma activity of daratumumab through augmentation of macrophage-induced ADCP

2018 - HAEMATOLOGICA

S, Naicker; A, Rigalou; C, Mcellistrim; R, Henderson; Natoni, Alessandro; C, Chiu; K, Sasser; A, Ryan; M, O'Dwyer

Novel kinase inhibitors afuresertib and PIM447 are active alone and in combination with standard therapies, respectively, in a predictive MM in vivo model, and a CRISPR genome-wide screening approach identifies clinically-relevant biomarkers determining susceptibility to these therapeutic strategies

2018 - HAEMATOLOGICA

N, Keane; Natoni, Alessandro; M, Sharik; M, Chesi; Pl, Bergsagel; M, O'Dwyer